Key result
The combination of dexmedetomidine and propranolol successfully attenuated signs and symptoms of refractory paroxysmal sympathetic hyperactivity in a pediatric patient following severe traumatic brain injury.
Why the study?
Does the combination of dexmedetomidine and propranolol improve symptoms of paroxysmal sympathetic hyperactivity in a pediatric patient following traumatic brain injury?
Case Report (n=1)
No
Does the combination of dexmedetomidine and propranolol improve symptoms of paroxysmal sympathetic hyperactivity in a pediatric patient following traumatic brain injury?
Dexmedetomidine and propranolol may be effective in attenuating signs and symptoms of paroxysmal sympathetic hyperactivity in pediatric patients following traumatic brain injury.
Answers are grounded in this paper and cite their sources.
May support dexmedetomidine-propranolol for refractory pediatric PSH; hypothesis-generating and needs prospective trials before adoption.
We report a case of pharmacologic management of pediatric paroxysmal sympathetic hyperactivity (PSH) in a patient who experienced symptomatic resolution with dexmedetomidine and propranolol. Following a blunt traumatic subdural hematoma and diffuse axonal injury, an 8-year-old male developed PSH on approximately day 5 of the hospitalization. PSH symptoms identified in this patient were hyperthermia, tachycardia, posturing, and hypertension with associated elevations in intracranial pressure. Episodes of PSH continued to be observed despite appropriate titration of opiates, sedatives, and traditional blood pressure management. Dexmedetomidine and propranolol were subsequently initiated to attenuate acute episodes of PSH. A reduction in sedative requirements and improvement in symptoms followed, which facilitated successful extubation. The combination of propranolol and dexmedetomidine was followed by a decrease in the frequency and severity of acute episodes of PSH. After utilization of multiple treatment modalities to control PSH episodes in our patient, propranolol and dexmedetomidine may have helped attenuate PSH signs and symptoms.
No takes yet. Share an insight, caveat, or question.
Branstetter et al. (2019) conducted a case report in Paroxysmal sympathetic hyperactivity following traumatic brain injury (n=1). Dexmedetomidine and Propranolol was evaluated on Symptomatic resolution of PSH. The combination of dexmedetomidine and propranolol successfully attenuated signs and symptoms of refractory paroxysmal sympathetic hyperactivity in a pediatric patient following severe traumatic brain injury.
Synapse has enriched 10 related papers. Consider them for comparative context: